AI assistant
Sending…
Rezolute, Inc. — Director's Dealing 2013
Feb 9, 2013
32362_dirs_2013-02-08_380692c9-0c56-40e8-9b4d-4ec2c293c049.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: AntriaBio, Inc. (ANTB)
CIK: 0001509261
Period of Report: 2013-01-31
Reporting Person: Kukekov Nickolay (Director)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2392000 | Direct |
| Common Stock | 1597074 | Indirect |
Footnotes
F1: Dr. Kukekov owns 2,392,000 shares of common stock of the Issuer.
F2: Dr. Kukekov is a non-controlling member of Chromium 24, LLC, a Delaware limited liability company. Dr. Kukekov does not have voting or dispositive power with respect to the shares of the Issuer's common stock held by Chromium 24, LLC. Dr. Kukekov disclaims beneficial ownership of the shares of the Issuer's common stock held by Chromium 24, LLC except to the extent of his pecuniary interest therein.
More from Rezolute, Inc.
Interim / Quarterly Report
2026
May 12
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 24
Major Shareholding Notification
2026
Feb 13
Regulatory Filings
2026
Feb 12
Interim / Quarterly Report
2026
Feb 12
Major Shareholding Notification
2026
Jan 30
Major Shareholding Notification
2026
Jan 8
Regulatory Filings
2026
Jan 7
Major Shareholding Notification
2025
Dec 19